logo

IPO

Share

biotechipo-jun14.jpg Marseille, France-based Innate Pharma S.A., is a biotechnology company developing therapeutic antibodies for the treatment of oncology indications with unmet medical need.

congatec Holding AG has decided to re-focus the IPO efforts to 2020 due to the current difficult market environment. The company said it will monitor the capital market environment in order to resume the IPO. Jason Carlson, CEO of congatec, said: "We will continue to focus on executing our growth...

biotechipo-jun14.jpg We are just one week into the fourth quarter of the year. The week that just wrapped up saw 3 biotech companies making their public debut, and one company, ADC Therapeutics, withdrawing its IPO filing, citing adverse market conditions.

biotechipo-jun14.jpg The IPO activity in the U.S. pharma/biotech sector has had a strong showing so far this year, with 46 listings in the 9-month period of the year and 12 listings in the third quarter.

Peloton Interactive Inc, the maker of high-end web-connected stationary bikes and treadmills, priced its initial public offering of about 40.00 million shares of class A common stock at $29.00 per share, which is the high end of the previously estimated range of $26.00 to $29.00 per share. The offering...

LOGISTRIAL Real Estate AG said it is preparing for an initial public offering in Germany. The company plans its shares to be listed on the regulated market of the Frankfurt Stock Exchange. The company will primarily use the proceeds from the IPO to acquire its initial property portfolio. LOGISTRIAL...

Anheuser-Busch InBev (AHBIF.PK, BUD) has priced the initial public offering of 1,262,350,000 shares of a minority stake of its Asia Pacific subsidiary, Budweiser Brewing Company APAC, at 27.00 Hong Kong Dollar per share. The expected gross proceeds are approximately $5.0 billion, prior to any exercise...

Envista Holdings Corp., a subsidiary of Danaher Corp. (DHR), said that it has priced its initial public offering of 26.77 million shares at $22.00 per share. The shares are expected to begin trading on the New York Stock Exchange under the ticker symbol "NVST." It is expected that the gross proceeds...

Ari Emanuel's company Endeavor Group Holding Monday announced plans to go public, according to a filing with the Securities and Exchange Commission. The entertainment, sports and content company plans to offer 19.35 million Class A shares at a price of $30 to $32 per share, which could raise up to...

biotechipo-sept13.jpg Mountain View, California-based IGM Biosciences is a biotechnology company developing engineered IgM antibodies for the treatment of cancer patients. Immunoglobulin M (IgM) is a class of antibody naturally produced by the human immune system.

Follow RTT
>